Mental Health-Sleep Overlap Global Market Report 2026

The mental health-sleep overlap market size has grown strongly in recent years. It will grow from $5.2 billion in 2025 to $5.72 billion in 2026 at a compound annual growth rate (CAGR) of 10%. The growth in the historic period can be attributed to rising prevalence of anxiety and depression disorders, increasing awareness of sleep disorders, expansion of behavioral therapy adoption, growth in telehealth mental health services, increasing research on sleep and circadian rhythm science.

The mental health-sleep overlap market size is expected to see rapid growth in the next few years. It will grow to $8.44 billion in 2030 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to growing adoption of personalized sleep-mental health treatment plans, increasing use of AI-driven behavioral analytics, rising employer investment in mental wellness programs, expansion of remote patient monitoring technologies, increasing integration of sleep biomarkers in psychiatric care. Major trends in the forecast period include increasing integration of sleep assessment in mental health screening, rising adoption of integrated CBT-I and CBT treatment programs, growing demand for digital sleep and mood monitoring tools, expansion of tele-psychiatry services addressing sleep disorders, rising focus on preventive mental health and sleep wellness programs.

The increasing prevalence of stress-related disorders is anticipated to drive the expansion of the mental health-sleep overlap market in the coming years. Stress-related disorders are conditions in which prolonged exposure to psychological or environmental stressors leads to symptoms such as anxiety, depression, emotional dysregulation, and impaired daily functioning. The incidence of these disorders is rising due to continuous exposure to chronic psychosocial stressors, including work-related pressures, financial burdens, social challenges, and lifestyle changes that overwhelm personal coping abilities and negatively impact mental well-being. Stress-related disorders are strongly associated with sleep disturbances, as persistent stress interferes with neurobiological mechanisms regulating mood and circadian rhythms, resulting in conditions such as insomnia, fragmented sleep, or hypersomnia. For example, in May 2024, according to the 2024 annual mental health poll conducted by the American Psychiatric Association, a US-based organization, 43% of adults reported feeling more anxious than the previous year, up from 37% in 2023 and 32% in 2022. Consequently, the growing prevalence of stress-related disorders is fueling the growth of the mental health-sleep overlap market.

Leading companies operating in the mental health-sleep overlap market are focusing on developing innovative solutions such as, artificial intelligence (AI)-powered mental health platforms to provide personalized, 24/7 support for stress and sleep-related issues. Artificial intelligence (AI)-powered mental health platforms are digital tools that use AI to deliver personalized mental health support, such as real-time guidance, coping strategies, and symptom monitoring, helping users manage stress, improve sleep, and access care anytime without waiting for in-person sessions. For example, in October 2025, Lyra Health, a US-based digital mental health company, launched Lyra AI, a clinical-grade AI platform designed to provide personalized mental health support. Lyra AI integrates advanced conversational AI with the existing Lyra Empower platform to deliver 24/7 guidance for challenges like stress, burnout, and sleep disturbances. The platform combines digital skill-building exercises with live provider sessions, features a risk-flagging system that escalates urgent cases to human clinicians, and adheres to strict clinical and ethical standards through its Polaris Principles. Its applications include improving sleep quality, reducing stress, and supporting overall mental wellness, offering scalable, evidence-based care while maintaining human oversight.

In May 2025, Lofta Inc., a US-based digital health company, formed a partnership with Bloom Mental Health LLC to integrate sleep apnea monitoring with mental health care solutions.With this collaboration, Lofta Inc. and Bloom Mental Health LLC aim to deliver comprehensive patient care by monitoring sleep patterns, facilitating early intervention for mental health issues associated with sleep disorders, and improving overall patient outcomes.Bloom Mental Health LLC is a US-based digital mental health startup specializing in services that address the intersection of mental health and sleep.

Major companies operating in the mental health-sleep overlap market are Johnson & Johnson, Koninklijke Philips N.V., Teladoc Health, Lyra Health Inc., Headspace Health Inc., Included Health Inc., Talkspace Inc., Spring Health, Whoop Inc., Transcarent Inc., Calm.com Inc., Modern Health Inc., Unmind Ltd., Big Health Inc., Click Therapeutics Inc., Welldoc Inc., Quartet Health Inc., Meru Health Inc., Ieso Digital Health Ltd., Wysa LTD., Oura Health Oy.

North America was the largest region in the mental health-sleep overlap market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mental health-sleep overlap market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the mental health-sleep overlap market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The mental health-sleep overlap market includes revenues earned by entities by providing services such as sleep therapy and counseling, cognitive behavioral therapy for insomnia (CBT-I), mental health therapy and counseling, stress management programs, sleep monitoring and coaching, digital health apps targeting sleep and mental well-being. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Mental health-sleep overlap refers to the significant, two-way relationship between sleep and mental health, where sleep quality, duration, and patterns both affect and are affected by psychological well-being. This overlap emphasizes shared biological, psychological, and behavioral mechanisms and highlights the importance of considering sleep as a central element of mental health assessment, prevention, and treatment.

The treatment and service offerings for mental health-sleep overlap comprise psychiatric pharmacotherapy with sleep effects, integrated programs combining cognitive behavioral therapy for insomnia (CBT-I) and cognitive behavioral therapy (CBT), tele-psychiatry or therapy services, digital monitoring and relapse prevention tools, and adjunct devices. Psychiatric pharmacotherapy with sleep effects refers to medications prescribed to manage mental health disorders while also addressing sleep disturbances. The target age groups include pediatric, adult, and geriatric populations, with delivery methods including mobile applications, web-based platforms, and telehealth integrations. The primary applications cover preventive healthcare and wellness, clinical treatment and disease management, and long-term care and assisted living, whereas the end-users or channels include outpatient mental health clinics, telehealth platforms, hospitals or behavioral health centers, employer or payer programs, and other relevant end users.

Tariffs on imported wearable devices, biometric sensors, and digital health hardware have influenced the mental health-sleep overlap market by increasing costs for adjunct devices such as sleep tracking watches and circadian rhythm regulation tools. Regions dependent on electronics manufacturing imports, including North America and Europe, are most affected. Telehealth platforms and digital monitoring tool providers may face higher equipment expenses, particularly in preventive and remote care segments. However, tariffs are also encouraging domestic production of digital health devices, localized software development, and innovation in cost-effective mental health monitoring solutions, strengthening regional health technology ecosystems.

The mental health-sleep overlap market research report is one of a series of new reports that provides mental health-sleep overlap market statistics, including mental health-sleep overlap industry global market size, regional shares, competitors with a mental health-sleep overlap market share, detailed mental health-sleep overlap market segments, market trends and opportunities, and any further data you may need to thrive in the mental health-sleep overlap industry. This mental health-sleep overlap market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

This product will be delivered within 1-3 business days.